Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
BCA Protein Quantification Kit K4102 Overview
2026-10-05
A concise, source-limited overview of APExBIO’s K4102 Bicinchoninic Acid Assay for research protein quantification, with no matched paper evidence.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody: Evidence Lens
2026-10-04
Explore how the FITC Goat Anti-Mouse IgG (H+L) Antibody supports interpretation of antiviral immunofluorescence and flow cytometry data. This article connects secondary-antibody signal biology with the Amt-1 influenza study while emphasizing evidence strength, assay boundaries, and translational relevance.
-
Cy5 Maleimide in Condensate Biology
2026-10-03
A charge-aware perspective on using cysteine-selective Cy5 probes to study α-synuclein condensates, molecular partitioning, and translational biomarker questions.
-
Cy5 amine (non-sulfonated) Labeling Protocol
2026-10-02
Cy5 amine (non-sulfonated), SKU A8143, provides a primary amino group for covalent attachment to compatible activated esters, activated carboxyl groups, or epoxides while supplying a near-red fluorescent readout. It is insoluble in water, so it should be dissolved in DMSO or ethanol before controlled transfer into an aqueous labeling workflow; it is not intended for diagnostic or medical use.
-
Dihydroquercetin and Wnt/β-Catenin in Porcine Cells
2026-10-01
The reference study shows that dihydroquercetin (DHQ, taxifolin) promotes IPEC-J2 porcine intestinal epithelial cell proliferation while increasing tight-junction and proliferation-associated markers through Wnt/β-catenin signaling. Its inhibitor-based design connects a flavonoid treatment to a defined signaling mechanism, although the findings remain primarily an in vitro cell-model result.
-
Cy5 maleimide (non-sulfonated): Practical Guide
2026-10-01
Cy5 maleimide (non-sulfonated) is a thiol-reactive labeling reagent for attaching a far-red fluorophore to cysteine-containing peptides and proteins through stable thioether bonds. It is appropriate for workflows that can manage low aqueous solubility and accessible thiols, but it is not a good choice when the target lacks reactive cysteines or direct dissolution in water is required.
-
Protease Inhibitor Cocktail for OXPHOS Assays
2026-09-30
Learn how the Protease Inhibitor Cocktail preserves protein integrity in OXPHOS cancer workflows. This evidence-aware guide connects LRPPRC–dasatinib biology with practical extraction, assay selection, and EDTA-free sample handling.
-
Ruxolitinib Phosphate: From JAK1/2 to Tumor Fate
2026-09-30
Ruxolitinib phosphate (INCB018424) offers translational researchers a precise way to connect JAK1/JAK2 inhibition with mitochondrial dynamics, apoptosis, and pyroptosis while preserving relevance to inflammatory and autoimmune disease models.
-
ARCA Cy5 EGFP mRNA: A Readout Architecture
2026-09-29
ARCA Cy5 EGFP mRNA (5-moUTP) enables a dual-readout strategy for separating mRNA delivery, localization, and translation. This article explains how cap biology, Cy5 tracking, EGFP expression, and immune-response controls can improve interpretation of mammalian-cell delivery studies.
-
From Sulfo-Cy5 Chemistry to Mucosal Vaccine Insight
2026-09-29
A translational framework for using Sulfo-Cy5 carboxylic acid to interrogate nanoparticle biodistribution, mucosal targeting, and immune-response mechanisms without overstating preclinical evidence.
-
Cy5 Maleimide for Condensate Assays
2026-09-28
Cy5 maleimide enables site-specific cysteine labeling for sensitive protein and condensate assays. This guide explains how non-sulfonated Cy5 maleimide can report molecular partitioning while controlling for dye charge, solvent effects, and labeling-induced artifacts.
-
JNJ-26481585 (Quisinostat) in Pituitary Tumor Research
2026-09-28
Use Quisinostat to investigate how broad HDAC inhibition intersects with TRIM21–ERK signaling and dopamine-agonist resistance in pituitary adenoma models. This practical workflow pairs early pathway readouts with proliferation and apoptosis assays so that changes in TRIM21 are not mistaken for proof of a specific mechanism.
-
SlSLAH1 Links STOP1 to Tomato Aluminum Tolerance
2026-09-27
A 2026 study identifies the plasma-membrane channel SlSLAH1 as a malate transporter that contributes to aluminum tolerance in tomato. It describes a regulatory module in which SlSTOP1–SlSZP1 activates SlSLAH1, while SlSLAH2 partners with SlSLAH1 to support malate exudation from roots.
-
EZ Cap Cy5 Firefly Luciferase mRNA for LNP Assays
2026-09-26
Separate cellular uptake from productive expression with Cy5 fluorescence and firefly luciferase in one reporter construct. A recent hepatic LNP study shows why ligand performance depends on PEG-lipid context—and how this dual-readout mRNA can help compare formulations without mistaking uptake for delivery success.
-
Aprotinin and GRO-seq: Protecting Assay Interpretability
2026-09-25
Aprotinin, or bovine pancreatic trypsin inhibitor, is best understood not only by its protease targets but also by where it belongs in an experimental workflow. This article connects its biochemical profile to a practical question raised by GRO-seq: how can sample-processing choices preserve interpretable results without introducing untested biological effects?